| Literature DB >> 36009928 |
Michael Edbert Suryanto1,2, Chun-Chuen Yang3,4, Gilbert Audira1,2, Ross D Vasquez5,6,7, Marri Jmelou M Roldan8, Tzong-Rong Ger9, Chung-Der Hsiao1,2,10,11.
Abstract
Antibiotics are extensively used in aquaculture to prevent bacterial infection and the spread of diseases. Some antibiotics have a relatively longer half-life in water and may induce some adverse effects on the targeted fish species. This study analyzed the potential adverse effects of antibiotics in zebrafish at the behavioral level by a phenomic approach. We conducted three-dimensional (3D) locomotion tracking for adult zebrafish after acute exposure to twenty different antibiotics at a concentration of 100 ppb for 10 days. Their locomotor complexity was analyzed and compared by fractal dimension and permutation entropy analysis. The dimensionality reduction method was performed by combining the data gathered from behavioral endpoints alteration. Principal component and hierarchical analysis conclude that three antibiotics: amoxicillin, trimethoprim, and tylosin, displayed unique characteristics. The effects of these three antibiotics at lower concentrations (1 and 10 ppb) were observed in a follow-up study. Based on the results, these antibiotics can trigger several behavioral alterations in adult zebrafish, even in low doses. Significant changes in locomotor behavioral activity, such as total distance activity, average speed, rapid movement time, angular velocity, time in top/bottom duration, and meandering movement are highly related to neurological motor impairments, anxiety levels, and stress responses were observed. This study provides evidence based on an in vivo experiment to support the idea that the usage of some antibiotics should be carefully addressed since they can induce a significant effect of behavioral alterations in fish.Entities:
Keywords: animal behavior; antibiotics; entropy; fractal dimension; phenomics
Year: 2022 PMID: 36009928 PMCID: PMC9404773 DOI: 10.3390/antibiotics11081059
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Characteristics of different antibiotics used in this study.
| No. | Class | Antibiotics | CAS No. | Purity (%) | Half-Life in Water (days) | Defined Daily Dose (DDD) * (g) | Concentration (s) Used in This Study (ppb) |
|---|---|---|---|---|---|---|---|
| 1 | Aminoglycosides | Amikacin | 37517-28-5 | 98 | 2–3 | 1 | 100 |
| Gentamycin | 1405-41-0 | 98 | 1–4 | 0.24 | 100 | ||
| Streptomycin | 3810-74-0 | 95 | 30.9 | 1 | 100 | ||
| 2 | Cephalosporins | Cefuroxime | 55268-75-2 | 99 | 2.8–3.3 | 0.5 | 100 |
| 3 | Fluoroquinolones | Ciprofloxacin | 86393-32-0 | 98 | 0.5–1 | 1 | 100 |
| Norfloxacin | 68077-27-0 | 98 | 5.3-5.9 | 0.8 | 100 | ||
| Ofloxacin | 82419-36-1 | 99 | 0.83–1 | 0.4 | 100 | ||
| 4 | Glycopeptides | Vancomycin | 1404-93-9 | 99 | 9–10 | 2 | 100 |
| 5 | Macrolides | Azithromycin | 83905-01-5 | 98 | 0.05–0.83 | 0.3 | 100 |
| Erythromycin | 114-07-8 | 95 | 5–365 | 1 | 100 | ||
| Tylosin | 1401-69-0 | 99 | 1.2–4.7 | 1.2 | 1, 10, 100 | ||
| 6 | Sulfonamides | Sulfamethazine | 1981-58-4 | 98 | 2.7–4.2 | 0.5 | 100 |
| Sulfamethoxazole | 723-46-6 | 98 | 0.42–2.4 | 2 | 100 | ||
| Sulfapyridine | 144-83-2 | 99 | 0.25–0.58 | 1 | 100 | ||
| Trimethoprim | 60834-30-2 | 98 | 20–100 | 0.4 | 1, 10, 100 | ||
| 7 | Tetracyclines | Doxycycline | 564-25-0 | 98 | 7–14 | 0.1 | 100 |
| Oxytetracycline | 2058-46-0 | 95 | 0.26–9 | 1 | 100 | ||
| Tetracycline | 64-75-5 | 99 | 20.6–106.6 | 1 | 100 | ||
| 8 | β-lactam | Amoxicillin | 26787-78-0 | 99 | 0.9–3.3 | 3 | 1, 10, 100 |
| Penicillin G | 113-98-4 | 96 | 4.1–11 | 3.6 | 100 |
* DDD: The assumed average maintenance dose per day for a drug used for its main indication in adults (based on WHO ATC/DDD guideline and index, 2021).
Summary of all endpoints used to generate data matrix to conduct PCA and clustering.
| No. | Behavior Endpoints | Definition | Interpretation |
|---|---|---|---|
| 1 | Total distance | The total distance traveled by zebrafish in the novel tank | This phenotype is representative of general motor and neurological characteristics. In general, zebrafish are very sensitive to non-specific motor disorders and the sedative effects of drugs |
| 2 | Average speed | Magnitude and direction of zebrafish speed | Based on the nature of the behavioral test, this value may be increased or decreased to reflect motor aspects of the zebrafish swimming |
| 3 | Average angular velocity | Angle of angular speed of zebrafish measured in magnitude and direction | Based on the nature of the behavioral test, this value may be increased or decreased to reflect motor aspects of the zebrafish swimming |
| 4 | Meandering | Turning degree (compared to straight locomotion) | Based on the nature of the behavioral test, this value may be increased or decreased to reflect motor aspects of the zebrafish swimming |
| 5 | Freezing time | The total duration of all freezing episodes (immobility) | Generally higher among stressed zebrafish and indicates increased anxiety |
| 6 | Swimming time | Total duration of all normal swimming bouts | Indicates a normal behavior and commonly observed, which may be maintained for minutes or hours |
| 7 | Rapid movement time | Total duration of all high swimming movement above the average speed | May be part of dashing or erratic movement as part of alarm reaction, typically triggered by acute stressors or characterized by baseline anxiety/fear |
| 8 | Time in top | The total amount of time spent in the upper portion of the novel tank | Low anxiety levels are reflected in a longer duration in the top of the tank |
| 9 | Time in middle | The total amount of time spent in the middle portion of the novel tank | Zebrafish dive to the bottom of novel tank as soon as they are introduced to a novel environment and start exploring as they become accustomed to it |
| 10 | Time in bottom | Total time spent in the lower portion of the novel tank | Zebrafish dive to the bottom of novel tank as soon as they are introduced to a novel environment and start exploring as they become accustomed to it |
| 11 | Thigmotaxis | A tendency to stay near the edge or side of an area (and avoid the center) | Zebrafish anxiety is measured by this parameter |
| 12 | Total distance traveled in top | The total distance traveled within the top portion of the defined area | Zebrafish with significant anxiety would move further in the tank’s bottom area |
| 13 | Total entries to the top | The number of crosses that run from the bottom of the novel tank to the top area. | Lower anxiety levels are associated with more top entries. |
| 14 | Fractal dimension | The variations or patterns in spatial complexity of zebrafish movement | Lower value indicates a decrease in complexity as a result of stressful or painful therapy, with arbitrary points reflecting the consequences of stress and mild, moderate, and severe pain |
| 15 | Entropy | Detecting behavioral changes in response to stressors by elucidating the time-space organized characteristic in behavioral data | A valuable tool for assessing behavioral complexity and tracking the influence of environmental stresses. The entropy decreases with increasing perturbation of the fish |
Figure 1Comparison of swimming movement activity of golden zebrafish after 10 days exposure with different antibiotics in 3D locomotion test. (A) Outlooking of 3D locomotion testing tank; (B) freezing movement time ratio; (C) swimming time ratio; and (D) rapid movement time ratio. The data were analyzed by ordinary one-way ANOVA followed by Dunnett’s multiple comparison test (n control: 24, n for each antibiotic group: 12). The significances were indicated by * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 (red asterisk indicates a higher mean value, while blue asterisk indicates a lower mean value than the control).
Figure 2Comparison of exploratory behavior of golden zebrafish after 10 days exposure with different antibiotics in 3D locomotion test. (A) Time in top area, (B) time in middle area, (C) time in bottom area, (D) distance to the center of the tank, (E) total distance traveled in the top area, and (F) total entries in the top area. The data were analyzed by ordinary one-way ANOVA followed by multiple comparison Fisher’s LSD test (n control: 24, n for each antibiotic group: 12). The significances were indicated by * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 (red asterisk indicates a higher mean value, while blue asterisk indicates a lower mean value than the control).
Figure 3Comparison of locomotor activity endpoints of golden zebrafish after 10 days exposure with different antibiotics in 3D locomotion test. (A) Total distance; (B) average speed; (C) average angular velocity; and (D) meandering. The data were analyzed by ordinary one-way ANOVA followed by multiple comparison Fisher’s LSD test (n control: 24, n for each antibiotic group: 12). The significances were indicated by * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 (red asterisk indicates a higher mean value, while blue asterisk indicates a lower mean value than control).
Figure A1Swimming trajectories comparison of zebrafish exposed to antibiotics in 3D locomotion test. (A) Control; (B) Amoxicillin 100 ppb; (C) Trimethoprim 100 ppb; and (D) Tylosin 100 ppb. The trajectories were made from the 1st min. of recorded 5 min. video by inputting the X, Y, Z position during time interval into OriginPro® software.
Figure 4Comparison of (A) fractal dimension (FD) and (B) entropy value in golden zebrafish locomotion after 10 days exposure with different antibiotics in 3D locomotion test. The data were analyzed by ordinary one-way ANOVA followed by multiple comparison Fisher’s LSD test (n control: 24, n for each antibiotic group: 12). The significances were indicated by * p < 0.05; ** p < 0.01 (red asterisk indicates a higher mean value, while blue asterisk indicates a lower mean value than control).
Figure 5Principal component (PCA) and hierarchical clustering analysis based on multiple behavior endpoints in golden zebrafish after 10 days exposure to different antibiotics. (A) PCA projects all behavior endpoints to explore the relationships in data among the antibiotic-treated/non-treated group. (B) Hierarchical clustering analysis of different behavior activity post-antibiotic treatment groups. Red indicates higher score of behavior endpoint, whereas blue indicates lower score of behavior endpoint.
Figure 6The locomotor activity endpoints of control and antibiotic-treated golden zebrafish after 10 days exposure. (A) Total distance traveled (cm); (B) average speed (cm/s); (C) average angular velocity (°/s); and (D) meandering movement (°/m). The data are expressed as mean ± S.E.M and were analyzed by ordinary one-way ANOVA followed by Dunnett’s test (n control: 12, n for antibiotic groups: 12, except n for AMX 1 ppb and TMP 10 ppb: 11, and n TYL 10 ppb: 10). The significances were indicated by * p < 0.05; ** p < 0.01, *** p < 0.001, and **** p < 0.0001 when compared to control group.
Figure A2The motility (swimming) behavior of control and low-dose antibiotic-treated zebrafish after 10 days exposure. (A) Freezing time movement ratio (%); (B) swimming time normal movement ratio (%); and (C) rapid movement time ratio (%). Abbreviation: AMX, Amoxicillin; TMP, Trimethoprim; TYL, Tylosin. The data are expressed as mean ± S.E.M and were analyzed by ordinary one-way ANOVA followed by Dunnett’s test (n control: 12, n for antibiotic groups: 12, except n for AMX 1 ppb and TMP 10 ppb: 11, and n TYL 10 ppb: 10). The significances were indicated by * p < 0.05; ** p < 0.01, and *** p < 0.001 when compared to control group.
Figure 7The exploratory behavior of control and antibiotic-treated golden zebrafish after 10 days of exposure. (A) Time in top duration (%); (B) time in middle duration (%); (C) time in bottom duration (%); (D) distance to the center of the tank (thigmotaxis) (cm); (E) total distance traveled in the top (cm); and (F) total entries top. The data are expressed as mean ± S.E.M and were analyzed by one-way ANOVA followed by Dunnett’s test (n control: 12, n for antibiotic groups: 12, except n for AMX 1 ppb and TMP 10 ppb: 11, and n TYL 10 ppb: 10). The significances were indicated by * p < 0.05; ** p < 0.01, *** p < 0.001, and **** p < 0.0001 when compared to control group.
Figure A3The comparison of (A) fractal dimension and (B) entropy value of control and antibiotic-treated zebrafish after 10 days exposure. The data were analyzed by ordinary one-way ANOVA followed by Dunnett’s test and compared to control group (n control: 12, n for antibiotic groups: 12, except n for AMX 1 ppb and TMP 10 ppb: 11, and n TYL 10 ppb: 10). Abbreviation: AMX, Amoxicillin; TMP, Trimethoprim; TYL, Tylosin.
Previously reported toxicological effects of amoxicillin, trimethoprim, and tylosin on aquatic organisms.
| Antibiotics | Concentrations | Exposure Period | Stages | Effects | Refs. |
|---|---|---|---|---|---|
| Amoxicillin | 100 ppm | 7 days | Adult zebrafish | Locomotor alteration and decreased social interaction | [ |
| 0, 75, 128, 221, 380, 654 and 1125 ppm | 96 h | Embryos and adult zebrafish | Caused premature hatching | [ | |
| 70 ppm | 7 days | Adult zebrafish | Decreased intestinal microbial diversity | [ | |
| 10, 11, 13, 15, 25, 40, 70, and 80 ppm | 96 h | Fingerlings and adult common carp | Behavioral, physical, and biochemical abnormalities | [ | |
| Trimethoprim | 0–100 ppm | 48 h | In vitro (rainbow trout gonad-2 cell) | Exhibit cytotoxic and genotoxic effects | [ |
| 200 ppb | 72 h | Zebrafish embryos | Embryotoxicity with reduced hatching rate, body malformations, and high mortality | [ | |
| 100 ppm | 48 h |
| Growth inhibition | [ | |
| 30–300 ppm | 5 days | Growth inhibition | [ | ||
| Tylosin | 5–400 ppb | 48 h | Phytoplankton | Growth inhibition | [ |
| 3–400 ppb | 7 days | Green algae | Growth inhibition | [ | |
| 0, 0.05, 0.2, 1, 5, 25, 100 ppm | 96 h | Zebrafish embryos | Decreased survival rate | [ | |
| 12.5 and 50 ppm | 48 h | Zebrafish embryos | Promoted tachycardia and bradycardia | [ |